Taisho Pharmaceutical Holdings Co., Ltd.
TAIPY · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $256 | $265 | $250 | $224 |
| Short-Term Investments | $0 | $7 | $4 | $14 |
| Receivables | $52 | $53 | $51 | $65 |
| Inventory | $53 | $45 | $46 | $43 |
| Other Curr. Assets | $14 | $8 | $6 | $9 |
| Total Curr. Assets | $376 | $379 | $358 | $356 |
| Property Plant & Equip (Net) | $141 | $119 | $113 | $113 |
| Goodwill | $128 | $126 | $129 | $170 |
| Intangibles | $110 | $87 | $88 | $40 |
| Long-Term Investments | $163 | $146 | $164 | $143 |
| Tax Assets | $7 | $10 | $9 | $11 |
| Other NC Assets | $16 | $21 | $16 | $20 |
| Total NC Assets | $566 | $509 | $519 | $497 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $941 | $888 | $877 | $853 |
| Liabilities | – | – | – | – |
| Payables | $17 | $15 | $15 | $18 |
| Short-Term Debt | $0 | $2 | $2 | $2 |
| Tax Payable | $2 | $4 | $3 | $5 |
| Deferred Revenue | $0 | $0 | -$2 | -$2 |
| Other Curr. Liab. | $55 | $41 | $38 | $41 |
| Total Curr. Liab. | $74 | $62 | $58 | $66 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $33 | $29 | $33 | $17 |
| Other NC Liab. | $26 | $29 | $28 | $28 |
| Total NC Liab. | $59 | $58 | $61 | $45 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $133 | $120 | $119 | $111 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $30 | $30 | $30 | $30 |
| Retained Earnings | $714 | $703 | $703 | $699 |
| AOCI | $64 | $36 | $32 | $18 |
| Other Equity | -$21 | -$21 | -$35 | -$35 |
| Total Equity | $787 | $748 | $730 | $712 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $23 | $20 | $29 | $30 |
| Total Liab. & Tot. Equity | $941 | $888 | $877 | $853 |
| Net Debt | -$256 | -$263 | -$249 | -$222 |